Belite Bio Adr Stock Probability of Future Stock Price Finishing Over 44.05
BLTE Stock | USD 64.15 0.55 0.85% |
Belite |
Belite Bio Target Price Odds to finish over 44.05
The tendency of Belite Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to stay above $ 44.05 in 90 days |
64.15 | 90 days | 44.05 | more than 93.0 |
Based on a normal probability distribution, the odds of Belite Bio to stay above $ 44.05 in 90 days from now is more than 93.0 (This Belite Bio ADR probability density function shows the probability of Belite Stock to fall within a particular range of prices over 90 days) . Probability of Belite Bio ADR price to stay between $ 44.05 and its current price of $64.15 at the end of the 90-day period is about 48.51 .
Given the investment horizon of 90 days Belite Bio has a beta of 0.85 suggesting Belite Bio ADR market returns are highly-sensitive to returns on the market. As the market goes up or down, Belite Bio is expected to follow. Additionally Belite Bio ADR has an alpha of 0.4158, implying that it can generate a 0.42 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Belite Bio Price Density |
Price |
Predictive Modules for Belite Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Belite Bio ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Belite Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Belite Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Belite Bio is not an exception. The market had few large corrections towards the Belite Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Belite Bio ADR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Belite Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.42 | |
β | Beta against Dow Jones | 0.85 | |
σ | Overall volatility | 12.41 | |
Ir | Information ratio | 0.08 |
Belite Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Belite Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Belite Bio ADR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Belite Bio ADR appears to be risky and price may revert if volatility continues | |
Net Loss for the year was (31.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Belite Bio ADR currently holds about 48.7 M in cash with (29.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.96. | |
Belite Bio ADR has a frail financial position based on the latest SEC disclosures | |
Roughly 59.0% of the company shares are held by company insiders | |
Latest headline from gurufocus.com: Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 |
Belite Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Belite Stock often depends not only on the future outlook of the current and potential Belite Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Belite Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 26.6 M | |
Cash And Short Term Investments | 88.2 M |
Belite Bio Technical Analysis
Belite Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Belite Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Belite Bio ADR. In general, you should focus on analyzing Belite Stock price patterns and their correlations with different microeconomic environments and drivers.
Belite Bio Predictive Forecast Models
Belite Bio's time-series forecasting models is one of many Belite Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Belite Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Belite Bio ADR
Checking the ongoing alerts about Belite Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Belite Bio ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Belite Bio ADR appears to be risky and price may revert if volatility continues | |
Net Loss for the year was (31.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Belite Bio ADR currently holds about 48.7 M in cash with (29.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.96. | |
Belite Bio ADR has a frail financial position based on the latest SEC disclosures | |
Roughly 59.0% of the company shares are held by company insiders | |
Latest headline from gurufocus.com: Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 |
Check out Belite Bio Backtesting, Belite Bio Valuation, Belite Bio Correlation, Belite Bio Hype Analysis, Belite Bio Volatility, Belite Bio History as well as Belite Bio Performance. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Return On Assets (0.26) | Return On Equity (0.40) |
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.